The ability to discover and market innovative drugs serves as the fuel for drug manufacturing industry vehicles. Large companies have the advantage of large scale and thus, comparatively lower costs of research, manufacturing, and marketing. For this very reason, the US drug manufacturing industry is highly concentrated, with the 50 largest companies accounting for more than 80 percent of total industry revenue. Eli Lilly and Company (LLY), one of the big names in this industry, has been constantly on the move striving to launch breakthrough drugs. Recently, the company's participation at the American Diabetes Association received a lot of appreciation based on the work it continues to undertake.
Let's take a look at the company's current advancements.
Eli Lilly has recently revealed results about its Phase III research for the treatment of Type II diabetes. Dulaglutide has an extensive plasma half-life of approximately 5 days with the